SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and intense debate as investors weigh the company's aggressive Bitcoin treasury strategy against concerns regarding shareholder dilution and broader market instability. The community remains deeply divided, with bulls pointing to the potential for significant long-term leverage, while bears and skeptics express concerns over high debt levels and the stock's recent performance relative to Bitcoin.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened volatility as retail investors debate whether current price levels represent a significant buying opportunity or a deeper correction fueled by broader market uncertainty and geopolitical concerns. While some in the community are actively organizing around the potential for a short squeeze due to high short interest and borrowing costs, others remain focused on the company's long-term enterprise growth and recent industry recognition.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is generating intense buzz as investors anticipate high-impact long-term efficacy data from the VELA Phase 3 trials at the upcoming American Academy of Dermatology conference. Community sentiment remains highly bullish, with many participants citing the potential for the drug to be classified as 'best-in-class' and speculating on an inevitable buyout by Big Pharma as institutional interest continues to mount.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as investors look toward the upcoming 10-K filing and earnings report, with the community closely tracking the company's debt reduction efforts and the performance of key holdings like Applied Digital and BW. Bullish sentiment remains high despite short-interest pressure, as retail investors anticipate a potential valuation re-rating driven by balance sheet improvements and strong asset performance.

Applied Digital Corporation

Applied Digital is experiencing significant volatility as investors weigh the stock's long-term potential in AI infrastructure against broader market pressures, including geopolitical instability and anticipation ahead of upcoming earnings. While some community members are expressing frustration over the recent sharp decline and delayed updates, others are viewing the current price levels as a strategic buying opportunity for long-term positions.

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals is trending following the FDA approval of EMPAVELI for rare kidney diseases, a long-awaited catalyst that de-risks the company and strengthens its nephrology portfolio. The community is actively debating the stock's future, balancing optimism over this label expansion and upcoming earnings with lingering frustration regarding management's past execution and previous revenue guidance challenges.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is trending amidst intense market volatility driven by escalating geopolitical tensions in the Middle East and concerns over energy costs, with community debate sharply divided between those viewing the price drops as a deep value accumulation opportunity and others predicting further downside. Investors are closely monitoring institutional flows and staking activities, even as short-term traders grapple with significant liquidations and widespread uncertainty about the asset's near-term decoupling from Bitcoin.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares (SOXS) is trending as traders debate the sustainability of recent rallies in the chip sector amidst heightened geopolitical uncertainty and oil market volatility. Community discourse is sharply divided between those positioning for a long-term semiconductor correction and those cautioning against holding structurally decaying inverse ETFs, especially as high-profile announcements from the AI space continue to fuel sentiment shifts.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently a focal point of intense community debate, driven by a mix of long-term sentiment among holders banking on institutional tokenization and a vocal group of traders focused on recent volatility and all-time low price points. Discussions are currently centered on the impact of a newly constituted Board of Directors and the project's pivot toward U.S. operations, with the community split between those accumulating 

WeShop Holdings Ltd. engages in providing a shoppable social network. It offers shopping in fashion and accessories, health and beauty, home and DIY, food and drink, travel and holidays, tech and electronics, and other popular categories. It includes a library of shoppable product reviews from a digital online shopping mall on mobile devices. The company was founded by John Garner on September 21, 2012 and is headquartered in Jersey, the United Kingdom.

WeShop Holdings Ltd - Ordinary Shares - Class A

WeShop Holdings Limited

WeShop Holdings is experiencing intense volatility and speculative interest from retail traders drawn to its unique community-owned, share-based shopping model. The community is actively debating the stock's potential for massive momentum-driven squeezes due to its low float and high borrow rates, while skeptics express concern over its lack of substantial revenue and potential for a rapid rug-pull.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lifeway Foods (NASDAQ:LWAY) Downgraded by Wall Street Zen to "Hold"

Wall Street Zen cut Lifeway Foods from a "buy" rating to a "hold" rating in a report on Saturday...

Insider Selling: Lifeway Foods (NASDAQ:LWAY) Major Shareholder Sells 10,000 Shares of Stock

Lifeway Foods, Inc. (NASDAQ:LWAY - Get Free Report) major shareholder Ludmila Smolyansky sold 10,000 shares of the company's stock in a transaction that occurred on Wednesday, March 18th. The stock...

Ludmila Smolyansky Sells 10,000 Shares of Lifeway Foods (NASDAQ:LWAY) Stock

Lifeway Foods, Inc. (NASDAQ:LWAY - Get Free Report) major shareholder Ludmila Smolyansky sold 10,000 shares of the firm's stock in a transaction on Wednesday, March 18th. The shares were sold at an average price of $18.74, for a total value of $187,400.00. Following the transaction, the insider...

Insider Selling: Lifeway Foods (NASDAQ:LWAY) Major Shareholder Sells 14,353 Shares of Stock

Lifeway Foods, Inc. (NASDAQ:LWAY - Get Free Report) major shareholder Edward Smolyansky sold 14,353 shares of the business's stock in a transaction that occurred on Thursday, March 19th. The stock was sold at an average price of $17.77, for a total value of $255,052.81. Following the sale, the...

Lifeway Foods (NASDAQ:LWAY) Major Shareholder Sells $448,491.30 in Stock

Lifeway Foods, Inc. (NASDAQ:LWAY - Get Free Report) major shareholder Edward Smolyansky sold 22,313 shares of the company's stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $20.10, for a total value of $448,491.30. Following the transaction, the insider...

Edward Smolyansky Sells 13,334 Shares of Lifeway Foods (NASDAQ:LWAY) Stock

Lifeway Foods, Inc. (NASDAQ:LWAY - Get Free Report) major shareholder Edward Smolyansky sold 13,334 shares of the business's stock in a transaction that occurred on Monday, March 16th. The shares...

Insider Selling: Lifeway Foods (NASDAQ:LWAY) Major Shareholder Sells 22,313 Shares of Stock

Lifeway Foods, Inc. (NASDAQ:LWAY - Get Free Report) major shareholder Edward Smolyansky sold 22,313 shares of the firm's stock in a transaction dated Tuesday, March 17th. The shares were sold at an...

Lifeway Foods Q4 Earnings Call Highlights

Lifeway Foods (NASDAQ:LWAY) executives highlighted record sales, margin expansion, and sharply higher profits in fiscal 2025, citing continued consumer demand for protein-rich and probiotic foods...

Lifeway Foods (NASDAQ:LWAY) Releases Earnings Results

Lifeway Foods (NASDAQ:LWAY - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported $0.15 EPS for the quarter, missing analysts' consensus estimates of $0.29 by...

Lifeway Foods Announces Strong Fourth Quarter and Record-Breaking Full Year 2025 Results Led by the Company's Flagship Kefir

Lifeway Foods Announces Strong Fourth Quarter and Record-Breaking Full Year 2025 Results Led by the Company's Flagship Kefir Lifeway Foods Announces Strong Fourth Quarter and Record-Breaking Full...

Lifeway Foods, Inc. engages in the manufacture of probiotic and nutritious foods. The firm's products include kefir, organic kefir, probiotic smoothie with collagen, muscle mates, probugs, and cheese. It distributes its products primarily through its direct sales force, brokers, and distributors. The company was founded by Michael Smolyansky and Ludmila Smolyansky in February 1986 and is headquartered in Morton Grove, IL.

Lifeway Foods, Inc.

iShares Dynamic Equity Active ETF ($BDYN)

Grayscale Bitcoin Trust ETF ($GBTC)

Destiny Tech100 Inc ($DXYZ)

Global X Defense Tech ETF ($SHLD)

The Modern Portfolio Builder. This award honors the fund that makes long-term investing easier, cheaper, or more effective for people who want to "set it and forget it."

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$0.20	--	--	N/A
Q4 '25	$0.29	$0.16	-44.83%	MISSED
Q3 '25	$0.28	$0.23	-17.86%	MISSED
Q2 '25	$0.18	$0.28	55.56%	BEAT
Q1 '25	$0.19	$0.23	21.05%	BEAT

LWAY
Lifeway Foods, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest LWAY News

LWAYLifeway Foods, Inc.